EZH2 and central nervous system cancer: In addition, part of HOTAIR effects in glioma may also be limited by using drugs directed to PRC2 components, as the EZH2 inhibitor DZNep [50], or drugs that specifically target LSD1 activity and have been tested in cancer [51, 52].